In vivo, experiments involving the injection of HCT116 and HT29 cells into immunodeficient mice revealed that mice injected with CCAT2‐KO cells exhibited significantly smaller tumor volumes and masses compared to those control cells. Here, CCAT2 is linked to neoplasm.